CBC Group (previously known as C-Bridge Capital) is a healthcare dedicated private equity firm, focused on growth and late stage investment opportunities with USD 2bn (USD + RMB) of assets under management. CBC's current portfolio includes China's leading players in pharmaceuticals, medical devices, diagnostics, and healthcare services. CBC is committed to support commercialization of cutting edge technologies and companies that fulfil unmet medical needs, thus continuously improving the standard and quality of care for patients.